These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30903308)

  • 1. Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.
    Pinto B; Janardana R; Nadig R; Mahadevan A; Bhatt AS; Raj JM; Shobha V
    Clin Rheumatol; 2019 Jul; 38(7):1931-1934. PubMed ID: 30903308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
    Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
    Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.
    Zhang X; Yang X; Ji L; Zhang Z
    Int J Rheum Dis; 2019 Jul; 22(7):1278-1282. PubMed ID: 31124267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the 2017 EULAR/ACR criteria for idiopathic inflammatory myopathies in a cohort of patients from Latin America.
    Valenzuela A; Torres M; Devés JD
    Medicine (Baltimore); 2022 Oct; 101(43):e31015. PubMed ID: 36316860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort.
    Yamazaki K; Ohta A; Akioka S; Yamasaki Y; Ohara A; Nakaseko H; Nishimura K; Kobayashi N; Nishida Y; Sato S; Takezaki S; Kishi T; Hashimoto M; Kobayashi I; Mori M;
    Rheumatology (Oxford); 2021 Feb; 60(2):802-808. PubMed ID: 32810274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
    Leclair V; Lundberg IE
    Curr Rheumatol Rep; 2018 Mar; 20(4):18. PubMed ID: 29550929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic inflammatory myopathies in adults: A comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria.
    Challa S; Jakati S; Uppin MS; Kannan MA; Liza R; Murthy Jagarlapudi MK
    Neurol India; 2018; 66(3):767-771. PubMed ID: 29766941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
    So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
    Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
    Jinnin M; Ohta A; Ishihara S; Amano H; Atsumi T; Fujimoto M; Kanda T; Kawaguchi Y; Kawakami A; Mimori A; Mimori T; Mimura T; Muro Y; Sano H; Shimizu J; Takeuchi T; Tanaka Y; Yamamoto K; Sumida T; Kohsaka H;
    Ann Rheum Dis; 2020 Mar; 79(3):387-392. PubMed ID: 31694813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.
    Parker MJS; Oldroyd A; Roberts ME; Lilleker JB; Betteridge ZE; McHugh NJ; Herrick AL; Cooper RG; Chinoy H
    Rheumatology (Oxford); 2019 Mar; 58(3):468-475. PubMed ID: 30496561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the EULAR/ACR 2017 idiopathic inflammatory myopathy classification criteria in juvenile dermatomyositis patients.
    Sag E; Demir S; Bilginer Y; Talim B; Haliloglu G; Ozen S
    Clin Exp Rheumatol; 2021; 39(3):688-694. PubMed ID: 33337999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Pak K; Huang W; Selva-O'Callaghan A; Albayda J; Casciola-Rosen L; Paik JJ; Tiniakou E; Mecoli CA; Lloyd TE; Danoff SK; Christopher-Stine L; Mammen AL
    Arthritis Rheumatol; 2022 Mar; 74(3):508-517. PubMed ID: 34480833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
    Saygin D; Glaubitz S; Zeng R; Bottai M; de Visser M; Dimachkie MM; Fiorentino D; Gerhardson I; Kuwana M; Miller FW; Needham M; Rider LG; Salem Y; Schlüter S; Shinjo SK; Wang G; Werth VP; Aggarwal R; Lundberg IE
    Clin Exp Rheumatol; 2024 Feb; 42(2):403-412. PubMed ID: 38436279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and diagnostic investigation in inflammatory myopathies: a study of 99 patients.
    Danielsson O; Lindvall B; Gati I; Ernerudh J
    J Rheumatol; 2013 Jul; 40(7):1173-82. PubMed ID: 23637317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of the 2017 ACR/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies.
    Sánchez-Mendieta GG; Vega-Morales D; Villarreal-Alarcón MÁ; Compean-Villegas JE; Moreno-Arquieta IA; Galarza-Delgado DÁ
    Reumatol Clin (Engl Ed); 2024 Mar; 20(3):142-146. PubMed ID: 38494305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Validation and Evaluation of Adding MRI or Extended Myositis Antibody Panel to the 2017 EULAR/ACR Myositis Classification Criteria.
    Luu Q; Day J; Hall A; Limaye V; Major G
    ACR Open Rheumatol; 2019 Sep; 1(7):462-468. PubMed ID: 31777826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.